STOCK TITAN

ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) Stock Price, News & Analysis

UCIB NYSE
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
11 239 sessions, September 15, 2025 to September 15, 2026
Largest daily move
+15.1% close of July 29, 2026
1-year change
+39.2% closing prices, September 15, 2025 to September 15, 2026
5-year change
+89.9% closing prices, September 15, 2021 to September 15, 2026

Company Description

UCIB has gained 39.2% over the past year. The last closing price was $38.07.

For FY2025, ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 reported revenue of $47.7B with net income of $3.6B. The company operates at a net profit margin of 7.5%.

This page collects what Stock Titan holds for UCIB, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

$37.88
+0.20%
+0.08
Last updated: September 15, 2026 at 14:42
+39.2%
Performance 1 year

ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) closed at $38.07 on September 15, 2026. Over the past 12 months, the price has gained 39.2%.

See what a $1,000 investment in UCIB would be worth today

UCIB Metrics & Rankings

Month to date
+2.2%
View ranking
YTD
+35.7%
View ranking

Price returns through September 15, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

Latest News

No recent news available for UCIB.

SEC Filings

ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 has filed 5 recent SEC filings, including 4 Form 6-K, 1 Form 25-NSE. The most recent filing was submitted on August 19, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all UCIB SEC filings →

Financial Highlights

ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 generated $47.7B in revenue in FY2025, and net income was $3.6B, reflecting a 7.5% net profit margin. The company generated $24.6B in operating cash flow.

$47.7B
Revenue (FY2025)
$3.6B
Net Income (FY2025)
$24.6B
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months

Short interest in ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) currently stands at 4.2 thousand shares, up 72.5% from the previous reporting period, representing 0.0% of the shares outstanding. Since September 2025, short interest has increased by 36.2%.

Days to Cover History

Last 12 Months

Days to cover for ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) currently stands at 3.2 days, down 33.9% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 216% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 18.8 days.

Frequently Asked Questions

What is the current quoted price of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB)?

The current quoted price of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) is $37.88 as of September 15, 2026.

What is the revenue of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) stock?

The FY2025 revenue of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) is $47.7B, from its most recent completed fiscal year.

What is the net income of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB)?

The FY2025 net income of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) is $3.6B, from its most recent completed fiscal year.

What is the operating cash flow of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB)?

The operating cash flow of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) is $24.6B. Learn about cash flow.

What is the profit margin of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB)?

The net profit margin of ETRACS UBS Bloomberg Constant Maturity Commodity Index (CMCI) Total Return ETN Series B due April 5, 2038 (UCIB) is 7.5%. Learn about profit margins.